AI Summary
✦ ClarthaValuation Metrics
Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.
5Y Average
4.53
Current
2.45
Overvalued
5.20
Undervalued
3.85
5Y Average
1.78
Current
1.28
Overvalued
2.04
Undervalued
1.51
Peers & Comparison
Sector: Materials · Theme: Specialty Chemicals
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
AMBICA AGAR & AROMAINDLTD AMBICAAGARSpecialty Chemicals | -28.3% | 2.4% | 12.2x Undervalued | -68% vs avg | -8.2% |
AKSHARCHEM INDIA LIMITED AKSHARCHEMSpecialty Chemicals | +16.6% | -0.1% | — | — | -2.2% |
AARTI SURFACTANTS LIMITED AARTISURFSpecialty Chemicals | +26.4% | 2.0% | 25.5x Undervalued | -33% vs avg | +14.2% |
NAVIN FLUORINE INT. LTD NAVINFLUORSpecialty Chemicals | +44.1% | 21.7% | 53.4x Premium | +40% vs avg | +67.4% |
AETHER INDUSTRIES LIMITED AETHERSpecialty Chemicals | +27.5% | 19.1% | 91.5x Premium | +140% vs avg | +116.4% |
ALKYL AMINES CHEM. LTD ALKYLAMINESpecialty Chemicals | -4.6% | 11.8% | 44.5x Premium | +16% vs avg | -8.7% |
ADVANCED ENZYME TECH LTD ADVENZYMESSpecialty Chemicals | +21.6% | 22.6% | 21.7x Undervalued | -43% vs avg | -1.8% |
ADVANCE AGROLIFE LIMITED ADVANCESpecialty Chemicals | +96.1% | 6.1% | 18.8x Undervalued | -51% vs avg | +17.4% |
Comparable-scale peer data is limited — showing nearest stored business/industry peers instead of an empty comparison.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹16 CrDec 2025Latest net profit
₹0.85 CrDec 2025Latest EPS
₹0.92Dec 2025Net margin
11.9%Dec 2025Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Dec 2025
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 57.2 | 37.52 | 43.37 | 32.65 | 37.05 | 23.86 | 18.96 | 18.1 | 14.08 | 7.44 | 17.42 | 15.65 |
| Expenses | 51.39 | 37.26 | 39.21 | 33.29 | 33.64 | 24.65 | 19.26 | 22.24 | 25.13 | 7.13 | 14.24 | 13.16 |
| Operating Profit | 5.19 | -0.35 | 3.55 | -1.27 | 2.74 | -1.4 | -0.92 | -4.76 | -11.71 | -0.32 | 2.55 | 1.86 |
| OPM % | 9.07% | -0.93% | 8.19% | -3.89% | 7.4% | -5.87% | -4.85% | -26.3% | -83.17% | -4.3% | 14.64% | 11.88% |
| Other Income | 0.03 | 0.03 | 0.01 | 0.01 | 0.41 | 0.37 | 0.2 | 0.03 | 1.38 | 0.02 | 0.01 | 0.05 |
| Interest | 0.37 | 0.96 | 1.02 | 1.08 | 1.72 | 1.14 | 0.99 | 0.95 | 0.9 | 0.61 | 2.19 | 1.09 |
| Depreciation | 0.62 | 0.61 | 0.61 | 0.63 | 0.67 | 0.61 | 0.62 | 0.62 | 0.66 | 0.63 | 0.63 | 0.63 |
| Profit before tax | 4.85 | -1.28 | 2.54 | -2.34 | 1.43 | -2.17 | -1.71 | -5.68 | -11.23 | -0.91 | 0.37 | 0.82 |
| Tax % | 26.8% | 2.34% | 4.72% | -0.85% | -34.27% | 1.84% | -7.02% | -0.53% | 6.23% | 4.4% | -8.11% | -3.66% |
| Net Profit | 3.55 | -1.25 | 2.42 | -2.36 | 1.92 | -2.13 | -1.83 | -5.71 | -10.53 | -0.87 | 0.4 | 0.85 |
| EPS in Rs | 3.85 | -1.36 | 2.62 | -2.24 | 2.09 | -2.31 | -1.98 | -6.19 | -11.42 | -0.94 | 0.43 | 0.92 |
All values in Rs. Crore unless otherwise stated. Source: CMIE Prowess, Quarterly Interim Standalone.